NCT02462863 is a NA clinical trial of Arginine and fish oil in Diabetes Mellitus, Type 2, sponsored by The Christ Hospital.

Who is sponsoring NCT02462863?

NCT02462863 is sponsored by The Christ Hospital.

What drugs are being tested in NCT02462863?

Interventions in NCT02462863: Arginine and fish oil.

What condition does NCT02462863 study?

NCT02462863 studies Diabetes Mellitus, Type 2.

Is NCT02462863 still recruiting?

NCT02462863 is currently completed. Last updated 1 October 2020.

Last reviewed 2020-10-01 · How we verify

NCT02462863

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Type 2 Diabetes With Immunonutrients

Completed NA Last updated 1 October 2020

What this trial tests

NA trial testing Arginine and fish oil in Diabetes Mellitus, Type 2 in 6 participants. Completed in 7 June 2017.

Timeline

1 March 2016

Primary endpoint
4 May 2017

7 June 2017

Quick facts

Lead sponsor	The Christ Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	6
Start date	1 March 2016
Primary completion	4 May 2017
Estimated completion	7 June 2017
Sites	1 location across United States

Drugs / interventions tested

Arginine and fish oil

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

The Christ Hospital

Who can join

Adults 18 to 65, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to determine if the nutrients arginine and fish oil will reverse or improve diabetes and to find out what additional good or bad effects a combination of arginine and fish oil may have. Both arginine and fish oil are common nutrients taken by normal people on a frequent basis. However, they have not been used in combination in the proposed doses to reverse diabetes once it is established. This study has been approved by the Food and Drug Administration (FDA investigational new drug \[IND\] 12191).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer.
Shum HCE, Wu K, Vadgama J, Wu Y. · · 2023 · cited 7× · PMID 36675817 · DOI 10.3390/jpm13010157

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other The Christ Hospital trials

Trials by the same sponsor.

NCT04513600 — ATTR-Cardiomyopathy Stabilization Following Tafamidis Therapy · unknown
NCT04355897 — CoVID-19 Plasma in Treatment of COVID-19 Patients · EARLY_PHASE1 · completed
NCT03923348 — Pelvic Floor Muscle Training With Leva System for Urge Incontinence · NA · terminated
NCT05210738 — Single-incision Sling vs Urethral Bulking During Prolapse Surgery for Occult Stress Incontinence · completed
NCT03633994 — Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy · Phase 2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02462863 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Christ Hospital
Last refreshed: 1 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02462863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing